Elin is a Post Doctoral Research Fellow in Melanoma within the School of Medical Sciences.
PhD (Doctoral Degree), South Africa, 2008.
M (Master Degree), Cuba, 2001.
B (Bachelor Degree), Cuba, 1997.
Recent Research Grants
Characterisation of Melanoma Circulating Tumour Cells for Personalised Treatment, Cancer Research Trust, Postdoctoral Fellowship,
2014 - 2019, $830,000.
Circulating Tumour DNA to Predict and Monitor Treatment Response and Detect
Acquired Resistance in Patients with Metastatic Melanoma, Ramaciotti Foundations, Grant,
2016 - 2017, $99,911.
Circulating Melanoma Cells as Predictive Biomarkers of Treatment Response and Disease Status, Cancer Council of WA Inc, Grant,
2015 - 2017, $111,519.
Using a Functional Protein Array to Identify Autoantibody Biomarkers with Diagnostic Potential for Melanoma, National Health and Medical Research Council, Development Grants,
2014 - 2017, $778,368.
Melanoma Mutation Profiling For Personalised Treatment, National Health and Medical Research Council, Project Grants,
2013 - 2016, $765,359.
Predictive significance of circulating tumour cells (CTCs), circulating tumour DNA (ctDNA) and serum vascular endothelial growth factor (VEGF) in advanced melanoma patients treated with pembrolizumab, Merck Sharp and Dohme (Australia) Pty Ltd, Grant,
2015 - 2016, $73,300.
Gene expression profiling of circulating tumour cells (CTCs) isolated from metastatic melanoma patients using a microfluidic chip, Cancer Council of WA Inc, Grant - Early Career Investigator,
Circulating Tumour Cells (CTCs) as a diagnostic tool to monitor disease progression in melanoma patients, Edith Cowan University, ECU Industry Collaboration Grant - 2015 (Round 1),
2015 - 2016, $137,227.
Mass Cytometry: A breakthrough in multidimensional systems biology, Australian Research Council, Grant - Linkage (Infrastructure),
Genetic Analysis of Melanoma Cells in Blood For Personalised Treatment Management, Edith Cowan University, ECU Early Career Researcher Grant - 2013,
2013 - 2014, $24,083.
Detection of Vemurafenib Resistance in Circulating Tumour Cells for Personalised Treatment of Melanoma, Harry Perkins Institute of Medical Research, Scott Kirkbride Melanoma Research Centre - Discovery Research Priming Grant,
2013 - 2014, $68,182.
Expanding Capacity and Capability in Western Australian Flow Cytometry for Earth, Oceans, Environmental and Biomedical Science: State-of-the-Art Four Laser and 12 Colour Analysis, Australian Research Council, Grant - Linkage (Infrastructure),
2012 - 2013, $598,000.
Detection of stem cell markers expression in circulating melanoma cells using multiparameter flow cytometry as a prognosis tool, Edith Cowan University, ECU Early Career Researcher Grant - 2012 (Round 1),
2012 - 2013, $19,480.
Neon Transfection System and Biomedical Research Grade -30oC Freezer for Alzheimer?s and Melanoma Research, National Health and Medical Research Council, Equipment Grant 2011,
2011 - 2012, $10,927.
Recent Publications (within the last five years)
Gray, E., Reid, A., Bowyer, S., Calapre, L., Siew, K., Pearce, R., Cowell, L., Frank, M., Millward, M., Ziman, M., (2015), Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment. Journal of Investigative Dermatology, 135(8), 2040-2048, London, United Kingdom, DOI: 10.1038/jid.2015.127.
Klinac, D., Gray, E., Freeman, J., Reid, A., Bowyer, S., Millward, M., Ziman, M., (2014), Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma. BMC Cancer, 14(1), Article number 423, United Kingdom, DOI: 10.1186/1471-2407-14-423.
Lacerda, M., Moore, P., Ngandu, N., Seaman, M., Gray, E., Murrell, B., Krishnamoorthy, M., Nonyane, M., Madiga, M., Wibmer, C., Sheward, D., Bailer, R., Gao, H., Greene, K., Karim, S., Mascola, J., Korber, B., Montefiori, D., Morris, L., Williamson, C., Seoighe, C., (2013), Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models. Virology Journal, 10(Article no. 347), 18 p., London, United Kingdom, DOI: 10.1186/1743-422X-10-347.
Moore, PL., Sheward, D., Nonyane, M., Ranchobe, N., Hermanus, T., Gray, E., Karim, SS., Williamson, C., Morris, L., (2013), Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies. Journal of Virology, 87(9), 4882-4894, United States, DOI: 10.1128/JVI.03424-12.
Calapre, L., Gray, E., Ziman, M., (2013), Heat stress: a risk factor for skin carcinogenesis. Cancer Letters, 337(1), 35-40, Ireland.
Klinac, D., Gray, E., Milward, M., Ziman, M., (2013), Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. Frontiers in Oncology, 3(March 2013), Article 00054, DOI: 10.3389/fonc.2013.00054.
Wibmer, C., Bhiman, J., Gray, E., Tumba, N., Abdool Karim, SS., Williamson, C., Morris, L., Moore, P., (2013), Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes. PLoS Pathogens, 9(10), 16p., United States, DOI: 10.1371/journal.ppat.1003738.
Freeman, J., Gray, E., Milward, M., Pearce, R., Ziman, M., (2012), Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells. Journal of Translational Medicine, 10(1), art. no. 192 , United Kingdom, DOI: 10.1186/1479-5876-10-192.